Standout Papers
Immediate Impact
1 from Science/Nature 98 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Works of Jun Yan being referenced
Nano-Chemotherapy synergize with immune checkpoint inhibitor- A better option?
2022
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
2012 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jun Yan | 351 | 317 | 470 | 647 | 72 | 1.5k | |
| Marcela Salomao | 396 | 380 | 618 | 570 | 62 | 1.9k | |
| Masaaki Kondo | 323 | 422 | 471 | 713 | 89 | 1.6k | |
| Yu‐Ming Wang | 331 | 276 | 356 | 364 | 114 | 1.6k | |
| Jung Hyun Kwon | 146 | 310 | 803 | 1065 | 107 | 1.8k | |
| Du Zhi | 543 | 239 | 294 | 432 | 87 | 1.8k | |
| Guihua Chen | 541 | 505 | 440 | 581 | 121 | 2.2k | |
| Sandra Koch | 377 | 281 | 518 | 545 | 58 | 1.6k | |
| Yoshiyuki Mori | 360 | 512 | 264 | 386 | 147 | 2.0k | |
| K. Sugiyama | 466 | 485 | 407 | 432 | 60 | 1.8k | |
| Vincenzo De Rosa | 308 | 577 | 214 | 259 | 78 | 1.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...